Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dexcom (DXCM) Other Non Operating Income (2016 - 2026)

Dexcom has reported Other Non Operating Income over the past 12 years, most recently at $14.2 million for Q1 2026.

  • Quarterly Other Non Operating Income fell 31.07% to $14.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $170.2 million through Mar 2026, up 73.32% year-over-year, with the annual reading at $176.6 million for FY2025, 62.02% up from the prior year.
  • Other Non Operating Income was $14.2 million for Q1 2026 at Dexcom, down from $17.7 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $109.8 million in Q3 2025 and troughed at -$1.3 million in Q3 2022.
  • The 5-year median for Other Non Operating Income is $22.4 million (2024), against an average of $24.8 million.
  • Year-over-year, Other Non Operating Income tumbled 900.0% in 2022 and then soared 2784.62% in 2023.
  • A 5-year view of Other Non Operating Income shows it stood at $8.0 million in 2022, then soared by 266.25% to $29.3 million in 2023, then fell by 23.55% to $22.4 million in 2024, then fell by 20.98% to $17.7 million in 2025, then fell by 19.77% to $14.2 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Other Non Operating Income are $14.2 million (Q1 2026), $17.7 million (Q4 2025), and $109.8 million (Q3 2025).